Roivant, continuing ascent, claims another victory for rare disease drug
Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also be a “best-in-disease” medicine for an inflammatory eye condition, one analyst said.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.